Hanger Ventures backed a socket-fit sensor startup. What an O&P network's investment means, and what it does not.
Hanger Ventures, the investment arm of the largest O&P provider network in the United States, has put money into Prosthetic Fit 360, maker of the Limn Fit sensor system. The announcement tells you something real about where socket sensing technology is heading—and something useful about the gap between a funding round and a fitting appointment.

Hanger Ventures announced an investment in Prosthetic Fit 360, the company behind the Limn Fit sensor-based socket monitoring system, according to The O&P EDGE. The press release describes a system designed to provide “continuous data-driven insights into prosthetic socket fit to improve clinical outcomes.”
That language is familiar — most O&P technology announcements use some version of it. What makes this one worth examining is not the technology description. It is who is making the investment.
Hanger Ventures is not a typical startup investor
Hanger Inc. is the largest orthotics and prosthetics provider in the United States, operating over 800 patient care clinics and serving more patients annually than any other O&P network in the country. Hanger Ventures is its strategic investment arm — not a general venture fund looking for financial returns in isolation, but a unit of a company whose business depends on clinical outcomes, patient retention, reimbursement rates, and the efficiency of the fitting process.
When a general VC backs socket sensing technology, it is a financial bet. When Hanger Ventures backs it, the bet has a different shape: the investor is also, potentially, the distribution channel, the data source, and the clinical deployment environment.
That distinction matters for how to interpret the announcement. If Prosthetic Fit 360 produces something Hanger ultimately integrates into its clinical workflows, the technology gains access to something most prosthetics startups cannot manufacture: a large, geographically distributed patient population, with consistent clinical infrastructure, across which a fit-sensing system can actually be tested and refined at scale.
What Limn Fit is measuring
The system is described as sensor-based and continuous, targeting insights about socket fit. “Continuous” is the operative word. The existing clinical baseline for socket fit assessment is a combination of patient report (“how does it feel”), visual skin inspection after doffing, and — in more instrumented research settings — discrete load cells embedded in a diagnostic socket. None of those provide ongoing measurement during daily activity.
What a continuous sensing system would add is a data stream: what the socket is doing during ambulation, during sitting and standing transitions, across different terrains, at different times of day. That last dimension is particularly relevant. Residual limb volume changes throughout the day — a biological fact that has been covered previously here and that every long-term prosthesis user encounters in practice. A socket that fits adequately at 8 a.m. may fit differently at 3 p.m. A system that records what is actually happening across that window is different from a system that captures a snapshot at a fitting appointment.
How Limn Fit specifically does this sensing — what the sensor architecture is, where it sits in the socket system, how it communicates data, and how a clinician interacts with the output — is not detailed in the announcement. The company name suggests comprehensive, surround-picture monitoring; “Limn” has historical meaning in cartography and illustration, the act of rendering something visible. What is visible to clinicians and patients after a Limn Fit session is the meaningful unknown.
For the engineering context on what continuous socket sensing requires to measure accurately — specifically why shear force is the harder problem compared to pressure — the Purdue–Notre Dame textile sensor piece from last week covers the technical terrain.
The path from investment to appointment room
The announcement does not describe Limn Fit as deployed across Hanger clinics. It describes an investment, which is an earlier step. Between an investment and a technology appearing in a clinical workflow, a sequence typically runs: product development and iteration, clinical studies to establish what the data predicts about outcomes, regulatory consideration if the system constitutes a medical device, clinical training, workflow integration, and a decision about how the service is billed — or whether it is bundled into the fitting process.
That sequence is not a formality. It is where most O&P technology products have stalled over the past decade. Sensor systems for socket monitoring have been in research stages at academic centers for years, with consistent findings that better fit data improves outcomes, and persistent difficulty translating that finding into something a practicing prosthetist can use at scale with a general patient population.
Hanger’s involvement does not eliminate those barriers. It changes the resources and incentives around them. A company with Hanger’s clinical reach and financial interest in fitting efficiency has reasons to push a product through the deployment sequence that an independent startup’s investors may not. Whether that translates to faster or more durable clinical integration depends on variables the announcement does not address.
What this means for the field
The practical import of this investment is longer-range than a single product. It signals that the largest O&P clinical network in the country has decided that continuous socket fit monitoring is worth a strategic bet — not just funding academic research, but backing a company positioned to bring a product to market.
That is a meaningful data point for the O&P field, where the gap between what research shows is possible and what is available in a typical clinical practice has been large and persistent. When Hanger moves toward a technology category, it affects what prosthetists at Hanger-affiliated clinics are trained on, what patients in those clinics encounter, and what the reimbursement conversation looks like if the service proves clinically valuable.
For patients: this is not a reason to ask your prosthetist next week whether they have Limn Fit. It is context for understanding that socket fit sensing is moving from a research concept toward a commercially backed product with a major deployment pathway attached.
The useful question, for now, is not “when can I get this” but “is my current prosthetist tracking the fit data that currently exists — fit check notes, skin inspection results, socket adjustment history — in a way that would let us see patterns over time?” That question is answerable today, with no new technology required, and often is not being asked.
Amputee News does not provide individualized medical, prosthetic fitting, or insurance advice. Technology investments and product development timelines described here are based on publicly available announcements. Whether any specific device or monitoring system is appropriate for a given patient depends on clinical evaluation by a certified prosthetist. If you have concerns about socket fit, contact your O&P provider.
Source notebook: This reporting draws on The O&P EDGE: Hanger Ventures Invests in Prosthetic Fit 360, August 2026 ↗. We link out so you can follow the receipts.